Oncosynergy

Developer of resistance mechanism inhibitors to treat cancer

placeSan Francisco, California, United States calendar_todayFounded 2011 groups3 employees language oncosynergy.com

Registered entities

Innovation

4 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 285 times.

YearFilings
20143
20152
20162
20173
20181
20191
20201
20211
20221
20231

Social engagement

Social engagement: 1.4K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Connecticut Innovations.

Investor typeCountShare
Venture capital117%
Angel & family office117%
Accelerator & incubator117%
Other / undisclosed350%
Coming soon